Articles

Congestive heart failure in patients with prediabetes and type 2 diabetes given TZDs might not carry the risk that is usually associated with congestive heart failure.

According to a new study, Type 2 diabetes patients are at increased risk for cardiovascular disease (CVD), yet a novel therapy employing the use of ezetimibe/simvastatin offers this patient population the option of lowering not only LDL-C, but also non-HDL-C, apo-B, and hs-CRP.

A diet rich in antioxidant vitamins and minerals (vitamins A, C, and E, various carotenoids, and zinc) did nothing to prevent age-related macular degeneration, according to a large review and meta-analysis.

New inhaled insulin shows less glucose excursions after meals then injected insulin.

A new cholesterol experimental drug by Merck & Co., from the same class as the one that failed for Pfizer, had dramatic results in a small clinical trial, raising HDL by 39% and lowering LDL by 40% without the safety problems that killed the Pfizer product.

Heart disease and stroke account for about 65 percent of deaths in people with diabetes

A mix of acetaminophen and caffeine may cause liver damage, especially in heavy caffeine drinkers, according to a study at the University of Washington in Seattle.

A new study shows that people with type 2 diabetes or elevated blood sugar are at increased risk of dying after being hospitalized for pneumonia.

New research shows increased prestroke comorbidity, particularly diabetes and coronary heart disease (CHD), is independently associated with poorer poststroke functional status among women with ischemic stroke.

Off-label use of exenatide for type 1 diabetic is effective for reducing A1c, insulin use and reducing weight.